EUVIMEDEUVIMED entdecken
Crossref

Immunological and Virological Characteristics of People Living with Human Immunodeficiency Virus on Antiretroviral Therapy in Bobo-Dioulasso Hospital, Burkina Faso

Suhaniwé Nina Pascaline Dakouo, Wilfried Wenceslas Bazié, Yacouba Sawadogo, Jacques Zoungrana, Arnaud Zougmoré, Firmin Nongodo Kaboré, Koiné Maxime Drabo, Armel Poda, Abdoul-Salam Ouédraogo

Journal of AIDS and HIV Treatment · 2024

DOI: 10.33696/aids.6.054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of AIDS and HIV Treatment, 2024. Verfasst von Suhaniwé Nina Pascaline Dakouo und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human immunodeficiency virus infection remains a public health challenge, mostly in sub-Saharan Africa. This region accounts for 65% of those infected and contributes to 50% of new infections. The World Health Organization advocates for early antiretroviral therapy (ART) initiation for all newly diagnosed individuals. If monitoring viral load (VL) after ART initiation is increasingly common, baseline VL testing is under-utilized in resource-limited settings. However, it is known that the baseline HIV viral load significantly influences the likelihood of achieving virological suppression in individuals starting antiretroviral therapy. The aim of this study was to investigate the immunological and virological profile of people living with HIV (PLWHIV) and associated factors at the initiation of ART.

Methods

We performed a retrospective analysis of data from an open cohort of PLWHIV followed at the Souro SANOU University Hospital adult day hospital who initiated antiretroviral therapy between January 2011 to October 2017. The analysis included patients who had a baseline HIV-1 viral load before ART initiation.

Results

There were 295 PLWHIV included, 67.1% of whom were female, and the median age was 39 years. The median viral load was 252,385 (IQR: 56,023-847,910) copies/mL and the median CD4 T cell count was 177 cells/μL (IQR:70–296). PLWHIV with baseline HIV-1 RNA >100,000 copies/mL and CD4+ count

Zitieren

APA

Dakouo, S. N. P., Bazié, W. W., Sawadogo, Y., Zoungrana, J., Zougmoré, A., Kaboré, F. N., Drabo, K. M., Poda, A., & Ouédraogo, A. (2024). Immunological and Virological Characteristics of People Living with Human Immunodeficiency Virus on Antiretroviral Therapy in Bobo-Dioulasso Hospital, Burkina Faso. Journal of AIDS and HIV Treatment. https://doi.org/10.33696/aids.6.054

Vancouver

Dakouo SNP, Bazié WW, Sawadogo Y, Zoungrana J, Zougmoré A, Kaboré FN, et al. Immunological and Virological Characteristics of People Living with Human Immunodeficiency Virus on Antiretroviral Therapy in Bobo-Dioulasso Hospital, Burkina Faso. Journal of AIDS and HIV Treatment. 2024. doi:10.33696/aids.6.054

BibTeX
@article{Dakouo2024,
  author = {Dakouo, Suhaniwé Nina Pascaline and Bazié, Wilfried Wenceslas and Sawadogo, Yacouba and Zoungrana, Jacques and Zougmoré, Arnaud and Kaboré, Firmin Nongodo and Drabo, Koiné Maxime and Poda, Armel and Ouédraogo, Abdoul-Salam},
  title = {Immunological and Virological Characteristics of People Living with Human Immunodeficiency Virus on Antiretroviral Therapy in Bobo-Dioulasso Hospital, Burkina Faso},
  journal = {Journal of AIDS and HIV Treatment},
  year = {2024},
  doi = {10.33696/aids.6.054}
}
Kostenlos starten →